Alternatives to ProtOS.bio

AI-powered platform for developing lipid nanoparticles for oligonucleotide therapies.

Computational platform using LLMs trained on biological and chemical data for drug discovery.

AI-driven platform for protein-level disease mapping and drug discovery.

Designs proteins with superior properties using computational analysis, evolutionary insights, and AI.

AI-powered blood test for early cancer detection and subtyping.

AI-powered insights platform for life sciences and biotech workflows.

Compressing biology to develop the next generation of therapies.

Pioneering precision microbiome therapeutics for oncology using CRISPR and synthetic biology.

Revolutionizing prenatal testing with non-invasive fetal DNA analysis from maternal blood.

Cloud-based platform for reproducible computational research in life sciences.

Synthetic biology startup optimizing gene expression for food and biotech applications.

Unleashing the power of genomics at scale for biological advances and human health.

AI-driven digital twin of embryo development for cell-based therapies.

Arrakis Bio is developing novel therapeutics for cancer and other diseases using a proprietary gene editing platform.

Life sciences data platform for deep-phenotype multi-omics datasets.

Developing a semiconductor-based protein detector using nanopore sensing for advanced identification.

Developing microbiome-derived therapies to overcome resistance to immune checkpoint inhibitors in cancer treatment.

Clinical-stage biotech developing a monoclonal antibody targeting TSLP for inflammatory diseases.

Developing novel therapeutics for rare genetic diseases.

Biopharmaceutical company developing targeted neutrophil nanoparticle platform for chronic diseases.